Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 1 - 10 of about 68   

Articles published

AZN 5,184.83 +27.83 (0.54%)
price chart
Did Say On Pay Cost A CEO His Job?
Likewise, at British drug maker AstraZeneca, CEO David Brennan announced two weeks ago that he would resign on June 1. AstraZeneca, hit by competition from generic drug manufacturers and the failure of several drugs in development, has seen shares ...
GSK rejects idea of buying AstraZeneca
L) has no interest in buying smaller rival AstraZeneca (AZN.L), GSK's chief executive said on Thursday in response to a shareholder question at the company's annual meeting.
Prostate-Cancer Test Not Worth Risk, Advisory Panel Says
A prostate cancer test used by half of men older than 40 isn't worth the risk of side effects from unnecessary treatment and shouldn't be used to diagnose the disease, a U.S.
Drugmakers' Deal With Obama Said to Be Probed by House
When that group didn't cooperate, the panel decided to target Pfizer, the world's biggest drugmaker, along with Merck, Amgen Inc., Abbott Laboratories and AstraZeneca Plc, said one of the people. The Republicans last month began negotiating directly ...
Glaxo to Begin Hostile Offer for Human Genome Sciences
Glaxo's bid is part of a wave of takeover activity in the pharmaceutical industry as drugmakers seek new products. Roche Holding AG made a hostile offer for Illumina Inc. in January, and abandoned it last month.
Aviva CEO Pressed to Step Down After Meeting Revolt
Moss, 54, is the latest CEO to come under pressure in a wave of protest from investors that has claimed the bosses of AstraZeneca Plc and Trinity Mirror Plc. Still nursing losses on bank and insurance stocks since the financial crisis, investors have ...
US to Seek New Uses for Abandoned Drugs
But researchers and the university or hospital involved will get patent rights for any new uses of the compound, according to the NIH and drug-company officials.
Glaxo Diabetes Drug Data Revealed Amid Hostile Takeover
... in January and currently the only once-weekly treatment for Type 2 diabetes on the market. Amylin, like Human Genome, has lured suitors for a takeover, including Pfizer Inc., AstraZeneca Plc and Merck & Co., people familiar with the matter said ...
India's Cipla Cuts Cancer Drug Prices by 75%
Bayer's patented medicine costs 280,000 rupees ($5,234) for a month. Cipla also slashed the cost of its copies of AstraZeneca PLC's lung-cancer drug Iressa by almost 60% and brain-cancer drug temozolamide by 75%. Bayer declined to comment on Cipla's ...
Eaton's Auto Roots Fade in $11.8 Billion Cooper Purchase
Eaton Corp.'s $11.8 billion acquisition of Cooper Industries Plc means electrical products such as equipment to illuminate buildings will generate the majority of the manufacturer's sales, marking the biggest move yet away from its 101-year-old roots ...